230 related articles for article (PubMed ID: 29109448)
1. Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay.
Watari A; Kodaka M; Matsuhisa K; Sakamoto Y; Hisaie K; Kawashita N; Takagi T; Yamagishi Y; Suzuki H; Tsujino H; Yagi K; Kondoh M
Sci Rep; 2017 Nov; 7(1):14514. PubMed ID: 29109448
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder.
Matsuhisa K; Kondoh M; Suzuki H; Yagi K
Biochem Biophys Res Commun; 2012 Jun; 423(2):229-33. PubMed ID: 22659740
[TBL] [Abstract][Full Text] [Related]
3. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
[TBL] [Abstract][Full Text] [Related]
4. A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide.
Uchida H; Kondoh M; Hanada T; Takahashi A; Hamakubo T; Yagi K
Biochem Pharmacol; 2010 May; 79(10):1437-44. PubMed ID: 20096266
[TBL] [Abstract][Full Text] [Related]
5. A Method to Prepare Claudin-Modulating Recombinant Proteins.
Tachibana K; Kondoh M
Methods Mol Biol; 2020; 2109():251-260. PubMed ID: 31471875
[TBL] [Abstract][Full Text] [Related]
6. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin.
Masuyama A; Kondoh M; Seguchi H; Takahashi A; Harada M; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
J Pharmacol Exp Ther; 2005 Aug; 314(2):789-95. PubMed ID: 15870390
[TBL] [Abstract][Full Text] [Related]
7. Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro.
Takahashi A; Kondoh M; Uchida H; Kakamu Y; Hamakubo T; Yagi K
Biochem Biophys Res Commun; 2011 Jul; 410(3):466-70. PubMed ID: 21672529
[TBL] [Abstract][Full Text] [Related]
8. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4.
Takahashi A; Kondoh M; Masuyama A; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
J Control Release; 2005 Nov; 108(1):56-62. PubMed ID: 16091298
[TBL] [Abstract][Full Text] [Related]
9. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells.
Noda S; Tanabe S; Suzuki T
Mol Nutr Food Res; 2013 Nov; 57(11):2019-28. PubMed ID: 23868418
[TBL] [Abstract][Full Text] [Related]
10. A novel strategy for the enhancement of drug absorption using a claudin modulator.
Kondoh M; Masuyama A; Takahashi A; Asano N; Mizuguchi H; Koizumi N; Fujii M; Hayakawa T; Horiguchi Y; Watanbe Y
Mol Pharmacol; 2005 Mar; 67(3):749-56. PubMed ID: 15602007
[TBL] [Abstract][Full Text] [Related]
11. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
[TBL] [Abstract][Full Text] [Related]
13. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.
Litkouhi B; Kwong J; Lo CM; Smedley JG; McClane BA; Aponte M; Gao Z; Sarno JL; Hinners J; Welch WR; Berkowitz RS; Mok SC; Garner EI
Neoplasia; 2007 Apr; 9(4):304-14. PubMed ID: 17460774
[TBL] [Abstract][Full Text] [Related]
14. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
Moran GW; O'Neill C; McLaughlin JT
Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
[TBL] [Abstract][Full Text] [Related]
15. Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction.
Ebihara C; Kondoh M; Harada M; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
Biochem Pharmacol; 2007 Mar; 73(6):824-30. PubMed ID: 17169334
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for
Vecchio AJ; Rathnayake SS; Stroud RM
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
[TBL] [Abstract][Full Text] [Related]
17. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.
Takahashi A; Komiya E; Kakutani H; Yoshida T; Fujii M; Horiguchi Y; Mizuguchi H; Tsutsumi Y; Tsunoda S; Koizumi N; Isoda K; Yagi K; Watanabe Y; Kondoh M
Biochem Pharmacol; 2008 Apr; 75(8):1639-48. PubMed ID: 18342294
[TBL] [Abstract][Full Text] [Related]
18.
Cuellar P; Hernández-Nava E; García-Rivera G; Chávez-Munguía B; Schnoor M; Betanzos A; Orozco E
Front Cell Infect Microbiol; 2017; 7():372. PubMed ID: 28861400
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy for a drug delivery system using a claudin modulator.
Kondoh M; Takahashi A; Fujii M; Yagi K; Watanabe Y
Biol Pharm Bull; 2006 Sep; 29(9):1783-9. PubMed ID: 16946486
[TBL] [Abstract][Full Text] [Related]
20. An intestinal paracellular pathway biased toward positively-charged macromolecules.
Almansour K; Taverner A; Turner JR; Eggleston IM; Mrsny RJ
J Control Release; 2018 Oct; 288():111-125. PubMed ID: 30194947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
